|Bid||33.10 x 400|
|Ask||33.24 x 500|
|Day's Range||33.01 - 33.48|
|52 Week Range||29.83 - 37.39|
|PE Ratio (TTM)||27.86|
|Dividend & Yield||1.28 (3.82%)|
|1y Target Est||N/A|
Top Analyst Reports for Oracle, Pfizer & Abbott
A Long Island, New York, investment adviser accused of engaging in insider trading after being tipped off about Pfizer Inc's $3.6 billion acquisition of King Pharmaceuticals Inc pleaded guilty on Tuesday, federal prosecutors said. Tibor Klein, 43, pleaded guilty to one count of conspiracy to commit securities fraud before U.S. District Judge Joan Azrack in federal court in Brooklyn, New York.
In 2016, Pfizer’s (PFE) Sutent reported revenues of ~$1.1 billion, which represented a ~2% decline on a YoY (year-over-year) basis.